Submission Details
| 510(k) Number | K143292 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 17, 2014 |
| Decision Date | August 04, 2015 |
| Days to Decision | 260 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
K143292 is an FDA 510(k) clearance for the TheraCal DC, a Liner, Cavity, Calcium Hydroxide (Class II — Special Controls, product code EJK), submitted by Bisco, Inc. (Schaumburg, US). The FDA issued a Cleared decision on August 4, 2015, 260 days after receiving the submission on November 17, 2014. This device falls under the Dental review panel. Regulated under 21 CFR 872.3250.
| 510(k) Number | K143292 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 17, 2014 |
| Decision Date | August 04, 2015 |
| Days to Decision | 260 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
| Product Code | EJK — Liner, Cavity, Calcium Hydroxide |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 872.3250 |